Synthetic Biologics
Patents, Design & Utilities
Last updated:
List of all Synthetic Biologics patents 43 in total
| Status | Patent |
|---|---|
Application | Utility: INTESTINAL ALKALINE PHOSPHATASE-BASED TREATMENTS OF METABOLIC DISORDERS Filling date: 7 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS Filling date: 7 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: BETA-LACTAMASE COMPOSITIONS FOR TREATMENT OF GRAFT VERSUS HOST DISEASE Filling date: 7 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS Filling date: 7 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION Filling date: 7 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY Filling date: 7 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO Filling date: 7 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Safe and effective beta-lactamase dosing for microbiome protection Filling date: 7 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Beta-lactamases with improved properties for therapy Filling date: 7 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME Filling date: 7 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: E. COLI-BASED PRODUCTION OF BETA-LACTAMASE Filling date: 7 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE Filling date: 7 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: ALKALINE PHOSPHATASE FORMULATIONS Filling date: 7 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: MICROBIOME PROTECTION FROM ORAL ANTIBIOTICS Filling date: 7 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: METHODS OF MAKING ALKALINE PHOSPHATASE AGENTS Filling date: 7 Sep 2025 Issue date: 24 Jun 2021 |
Grant | Utility: E. coli-based production of beta-lactamase Filling date: 7 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Alkaline phosphatase formulations Filling date: 7 Sep 2025 Issue date: 27 Apr 2021 |
Application | Utility: ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS Filling date: 7 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS Filling date: 7 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS Filling date: 7 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: ANTI-METHANOGENIC LOVASTATIN ANALOGS OR DERIVATIVES AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: BETA-LACTAMASE FORMULATIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: CLINICALLY EFFICACIOUS ANTI-METHANOGENIC COMPOSITIONS AND USES Filling date: 7 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS Filling date: 7 Sep 2025 Issue date: 10 Dec 2020 |
Grant | Utility: Beta-lactamase formulations and uses thereof Filling date: 7 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY Filling date: 7 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: ANTI-METHANOGENIC COMPOSITIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 15 Oct 2020 |
Grant | Utility: Method and compositions for inhibiting or preventing adverse effects of oral antibiotics Filling date: 7 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION Filling date: 7 Sep 2025 Issue date: 24 Sep 2020 |
Grant | Utility: Beta-lactamases with improved properties for therapy Filling date: 7 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Anti-methanogenic lovastatin analogs or derivatives and uses thereof Filling date: 7 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME Filling date: 7 Sep 2025 Issue date: 16 Jul 2020 |
Grant | Utility: Safe and effective beta-lactamase dosing for microbiome protection Filling date: 7 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Anti-methanogenic compositions and uses thereof Filling date: 7 Sep 2025 Issue date: 2 Jun 2020 |
Application | Utility: BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY Filling date: 7 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: BETA-LACTAMASE FORMULATIONS Filling date: 7 Sep 2025 Issue date: 9 Apr 2020 |
Grant | Utility: Beta-lactamases with improved properties for therapy Filling date: 7 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Carbapenemases for use with antibiotics for the protection of the intestinal microbiome Filling date: 7 Sep 2025 Issue date: 4 Feb 2020 |
Application | Utility: BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY Filling date: 7 Sep 2025 Issue date: 16 Jan 2020 |
Grant | Utility: Humanized pertussis antibodies and used thereof Filling date: 7 Sep 2025 Issue date: 7 Jan 2020 |
Application | Utility: ANTI-METHANOGENIC COMPOSITIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE Filling date: 7 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: ANTI-METHANOGENIC COMPOSITIONS Filling date: 7 Sep 2025 Issue date: 12 Sep 2019 |
Showing 1 to 43 of 43 patents.